Esomeprazole and omeprazole could raise the serum concentrations of benzodiazepines (via CYP2C19 inhibition) resulting in amplified adverse effects including drowsiness, although the clinical relevance is reduced in most patients – monitor the affected individual for adverse effects (e.If client are not able to resume their usual oral medication